AEterna Zentaris Inc. (AEZS)

[alexander77]

My takeaway from the CC: Sufficient money to continue operation until at least the start of commercialization of Zoptrex and Macrilen (if approved). Great CC, Dodd sounded very confident. IMO management has a lot of faith that Macrilen and Zoptrex (overall survival of Zoptrex + specific methods of the oncologists will be higher than Dox + specific method of the oncologists). Only 13.5 million shares outstanding.
If Macrilen gets a yes from the FDA and if Zoptrex results are positive, share price will be $40/share to start with